An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
For journalists and other media professionals
In a recent letter in the St. Louis Times Dispatch, Drs. Palmisano and Gale stressed the importance of establishing open, transparent procedures in the Patient-Centered Outcomes Research Institute.
Partnership to Improve Patient Care (PIPC) Chairman Tony Coelho recently discussed the importance of patient-centered CER at a Health Affairs briefing entitled “Comparative Effectiveness Research Enters New Era” in Washington, D.C.
A new Health Affairs article concludes, based on focus groups and interviews, that "consumers will revolt if evidence-based efforts are perceived as rationing or as a way to deny them needed treatment."
You don't need to look any further than public reaction to the U.S. Preventive Service Task Force's updated recommendations on mammography screening to see the proof of this.
How should policy-makers react? Should they conclude that consumers, and even more so, patients, cannot be relied on to make evidence-based decisions, and therefore these decisions need to be made for them? Or should they conclude that evidence-based models of medical care and health delivery need to be carefully constructed so they have the trust and support of patients and consumers?